Merrell Advances Running Innovation with the Launch of the High-Tech ProMorph Hybrid
Engineered for runners who move between roads and trails, the ProMorph blends responsive foam and all-terrain traction
ROCKFORD, Mich., June 30, 2025 /PRNewswire/ — Merrell, the world's leading hiking and outdoor footwear brand, is expanding its performance running portfolio with the debut of the ProMorph, an all-terrian hybrid built with responsive cushioning and confident grip across any surface. The ProMorph merges the DNA of an elite road racer with the technicality of a trail shoe, making it Merrell's most well-rounded hybrid to date.
Designed for runners seeking a one-stop shop shoe that can carry them across long distances and varying terrain, the ProMorph is built with energy-efficient FloatPro+ foam, offering lightweight rebound over extended periods of time. FLEXconnect® dual-directional flex grooves enhance stability and ground feel, while a Vibram® XS Trek Evo outsole provides versatile grip on both wet and dry ground, allowing for confident movement whether you're on asphalt or mountain switchbacks.
'At Merrell, we're reimagining what performance looks like for today's runner by merging our trail heritage with modern innovation,' said Richard McLeod, Chief Marketing Officer for Merrell. 'The ProMorph exemplifies how we're evolving—delivering a hybrid design that's not just versatile but engineered with our most advanced foam and traction technologies to meet the expectations of a new generation of athletes. It's a bold step forward in redefining what Merrell stands for in the running space.'
With a stack height of 32.5mm in the heel and a 6mm drop, the ProMorph is tuned for high-cushion performance without sacrificing control. The athletic fit locks in the foot while maintaining breathability and comfort for ultra-distance efforts, making it a trusted go-to from daily training to race day use.
To celebrate the launch of the ProMorph, Merrell sponsored team 'Loose Footage' at the 2025 Southbound 400, an unsanctioned 400-mile relay race from the Canadian border to Manhattan held on May 16. The race had no permits, no official course markings and no designated hand-off points—just one rule: a runner must be moving at all times. Team Loose Footage took third place overall, completing the race in the ProMorph.
The ProMorph will be available for $150 in men's and women's models, launching on July 1, 2025, at Merrell.com and select retailers.
ABOUT MERRELL:Merrell exists to share the simple power of being outside and is committed to building an inclusive and sustainable environment for future generations to enjoy. As the global leader in outdoor active footwear with the Moab hiking boot and Jungle Moc, Merrell is focused on merging performance, styling, and comfort to empower all people to explore the outdoors confidently. The brand was recently named Footwear News' 2022 Brand of the Year for promoting a more diverse vision of the outdoors. Visit Merrell.com or follow us on social @Merrell. Merrell is a division of Wolverine World Wide, Inc. (NYSE: WWW), one of the world's leading marketers and licensors of branded casual, active lifestyle, work, outdoor sport, athletic, children's, and uniform footwear and apparel.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
12 hours ago
- Malaysian Reserve
Pet King Brands' ZYMOX® Designated as a 2025 Vanguard Awards Winner in Eye and Ear Care
Pet Insight Magazine recognizes ZYMOX as a category trailblazer. AUSTIN, Texas, June 30, 2025 /PRNewswire/ — Pet King Brands, a pioneering leader in veterinarian-recommended enzymatic pet health products, including ZYMOX Dermatology and Oratene® Brushless Oral Care, is honored to announce their recognition as a Pet Insight Magazine 2025 Vanguard Award recipient. The annual awards program certifies category giants through their leadership, innovation and partnership, 'pushing forward trustworthy solutions in their categories, backing up their innovations with more research than ever,' says Pet Insight. Pet King Brands leads the eye and ear care category with an emphasis on safe, effective and natural solutions in accessible and convenient formats. 'We use only natural, enzyme-based formulas to provide therapeutic relief from common pet ailments,' said Debra Decker, Director of Marketing of Pet King Brands, in an interview with Pet Insight. 'Our LP3 Enzyme System sets us apart by targeting the root causes of infections, reducing the frequency of chronic issues and providing lasting relief all while offering preventative protection for long-term health. The enzymes in ZYMOX products are derived from natural dairy sources, ensuring that pets receive a chemical-free, gentle experience without harmful side effects.' Learn more about this year's Pet Insight 'Vanguard Awards' and see a complete list of winners here. About Pet King BrandsPet King Brands, proud sponsors of The Westminster Kennel Club's 149th Dog Show and makers of ZYMOX® Ear and Skin, Oratene® Brushless Oral Care, Equine Defense®, and ZYLAFEN™ products, is a leader in veterinarian-approved pet products made in the USA. Focused on the health and wellness of small and large animals of all ages, the products utilize the power of the LP3 Enzyme System and have been resolving ear, skin and oral conditions for over 25 years. Led by President and Founder Pamela Bosco, with the help of her bioscientist brother, Michael Pellico, Pet King Brands has revolutionized the way people care for animals' ears, skin and mouths, offering solutions that are gentle, easy to administer and free of harsh chemicals and antibiotics.
Malaysian Reserve
14 hours ago
- Malaysian Reserve
FMC Corporation expands novel fluindapyr fungicide technology to EMEA region
Tremisia® fungicide receives registration in Ukraine, bringing growers a new tool to combat challenging crop diseases PHILADELPHIA, June 30, 2025 /PRNewswire/ — FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced regulatory approval for Tremisia® fungicide in Ukraine, marking the first introduction of the company's novel fluindapyr technology in the European, Middle East, and Africa (EMEA) region. The approval covers oilseed rape, sunflower, and wheat across more than 10 million hectares of Ukrainian farmland. 'The registration advances the commercialization of FMC's novel fluindapyr fungicide technology,' said Sebastià Pons, vice president, president of FMC EMEA. 'Ukraine ranks among the world's largest exporters of sunflower, oilseed rape, and wheat, making it a strategically important agricultural market. The Tremisia® fungicide approval brings Ukrainian growers our most advanced fungicide technology and demonstrates FMC's continued commitment to science and innovation.' Tremisia® fungicide combines FMC's proprietary fluindapyr molecule with flutriafol, delivering a dual mode of action to help maintain a healthy crop for an extended period. This fungicide targets a broad spectrum of economically significant diseases, including Alternaria and Sclerotinia in sunflower, and Septoria and rust in wheat. 'This registration fills an important gap in disease management options for Ukrainian growers, providing a high-performance tool to protect their crops from devastating disease,' said Nataliia Savchenko, FMC Ukraine country leader. 'Disease pressures pose ongoing challenges to crop productivity in Ukraine's intensive cropping systems. Tremisia® fungicide will offer growers the freedom to choose a best-in-class solution that integrates seamlessly into their existing disease management programs.' The Ukraine registration builds on FMC's successful commercialization of fluindapyr-based products in Argentina, Brazil, Mexico, Paraguay, South Korea, and the United States, with conditional approval secured in the Philippines earlier this year. Pending regulatory decisions, FMC anticipates launching fluindapyr-based products in Bolivia, Chile, Colombia, Honduras, and India, further expanding global access to this innovative fungicide technology. About FMC FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC's innovative crop protection solutions – including biologicals, crop nutrition, digital and precision agriculture – enable growers and crop advisers to address their toughest challenges economically while protecting the environment. FMC is committed to discovering new herbicide, insecticide and fungicide active ingredients, product formulations and pioneering technologies that are consistently better for the planet. Visit to learn more and follow us on LinkedIn®. Tremisia is a trademark of FMC Corporation and/or an affiliate. Always read and follow all label directions, restrictions and precautions for use. Products listed here may not be registered for sale or use in all states, countries or jurisdictions. Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995: FMC and its representatives may from time to time make written or oral statements that are 'forward-looking' and provide other than historical information, including statements contained in this press release, in FMC's other filings with the SEC, and in presentations, reports or letters to FMC stockholders. In some cases, FMC has identified these forward-looking statements by such words or phrases as 'outlook', 'will likely result,' 'is confident that,' 'expect,' 'expects,' 'should,' 'could,' 'may,' 'will continue to,' 'believe,' 'believes,' 'anticipates,' 'predicts,' 'forecasts,' 'estimates,' 'projects,' 'potential,' 'intends' or similar expressions identifying 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the risk factors included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2024 (the '2024 Form 10-K'), the section captioned 'Forward-Looking Information' in Part II of the 2024 Form 10-K and to similar risk factors and cautionary statements in all other reports and forms filed with the Securities and Exchange Commission ('SEC'). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Forward-looking statements are qualified in their entirety by the above cautionary statement. We specifically decline to undertake any obligation, and specifically disclaims any duty, to publicly update or revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events, except as may be required by law.
Malaysian Reserve
15 hours ago
- Malaysian Reserve
Cymbiotika Celebrates 2025 Great Place To Work Certification™
A Testament to Thriving Culture and Team Spirit SAN DIEGO, June 30, 2025 /PRNewswire/ — Cymbiotika is proud to be Certified™ by Great Place To Work® for the 4th year in a row. The prestigious award is based entirely on what current employees say about their experience working at Cymbiotika. Great Place To Work® is the global authority on workplace culture, employee experience, and the leadership behaviors proven to deliver market-leading revenue, employee retention and increased innovation. 'Great Place To Work Certification is a highly coveted achievement that requires consistent and intentional dedication to the overall employee experience,' says Sarah Lewis-Kulin, the Vice President of Global Recognition at Great Place To Work. She emphasizes that Certification is the sole official recognition earned by the real-time feedback of employees regarding their company culture. 'By successfully earning this recognition, it is evident that Cymbiotika stands out as one of the top companies to work for, providing a great workplace environment for its employees.' 'Being awarded Great Place to Work is a powerful reminder that culture is our greatest asset. When we lead with purpose, prioritize well-being, and create space for every voice, we build more than a company—we build a community. ' Durana Elmi, Co- Founder, COO. This year, we focused on giving back to the community of San Diego; implementing more opportunities for our team to volunteer with Surfrider San Diego, Feeding America, Urban Street Angels, Animal Pad and more. We know that true wellness is brought forth when we support others mentally, physically and emotionally. As a team, we can go further when we go together and our employees feel empowered by the impact they are leaving behind. According to Great Place To Work research, job seekers are 4.5 times more likely to find a great boss at a Certified great workplace. Additionally, employees at Certified workplaces are 93% more likely to look forward to coming to work, and are twice as likely to be paid fairly, earn a fair share of the company's profits and have a fair chance at promotion. About Cymbiotika At Cymbiotika, co-founded by Durana Elmi, Shahab Elmi, and Chervin Jafarieh, we believe that wellness starts with trust. That's why we're committed to creating supplements that are not only effective but also transparent. From the moment you pick up one of our products, you'll know exactly what's inside—no hidden ingredients, no confusing labels. We take pride in using only the highest-quality ingredients, carefully sourced and backed by science, to ensure you're getting the best of nature and innovation in every supplement. We understand that health is personal, which is why our supplements are designed to work with your body, not against it. By focusing on bioavailability and using advanced liposomal delivery systems, we ensure that your body can absorb and use the nutrients to their fullest potential. Our goal is simple: to help you feel your best, with products you can trust, made with ingredients you feel good about. With Cymbiotika, you're not just taking a supplement—you're joining a community of people who value wellness, science, and the power of transparency. We're here to empower you on your journey to better health, every step of the way. Follow Cymbiotika here: @cymbiotika About Great Place to Work Certification™ Great Place To Work® Certification™ is the most definitive 'employer-of-choice' recognition that companies aspire to achieve. It is the only recognition based entirely on what employees report about their workplace experience – specifically, how consistently they experience a high-trust workplace. Great Place to Work Certification is recognized worldwide by employees and employers alike and is the global benchmark for identifying and recognizing outstanding employee experience. Every year, more than 10,000 companies across 60 countries apply to get Great Place To Work-Certified. About Great Place To Work® As the global authority on workplace culture, Great Place To Work® brings 30 years of groundbreaking research and data to help every place become a great place to work for all. Their proprietary platform and For All™ Model helps companies evaluate the experience of every employee, with exemplary workplaces becoming Great Place To Work Certified™ or receiving recognition on a coveted Best Workplaces™ List. Learn more at and follow Great Place To Work on LinkedIn, Twitter, Facebook and Instagram.
